Subject Screening For Clinical Trial
Efficient, Remote, and Patient-Centric
Remote Screening Tools for Subject Participation
In an era where digital technology is revolutionizing healthcare, we have embraced remote screening tools to identify and evaluate potential participants for our clinical trials. This not only broadens our reach but also makes the process more convenient and less burdensome for patients.
Collaboration with Patient Advocacy Groups and Clinics
Key to our screening process is our collaboration with Patient Advocacy Groups and clinics. By partnering with these groups, we can identify potential subjects more efficiently, ensuring that those who could most benefit from our trials have the opportunity to participate.
Sample Acquisition and Molecular Analysis
Our comprehensive screening process includes sample acquisition and molecular analysis, including genetics, when relevant. This allows us to identify the most suitable participants for our trials and ensure our studies are as targeted and effective as possible.
At Uncommon Cures, we believe in making the uncommon possible. Our unique approach to subject screening for clinical trials reflects our commitment to patient-centered, efficient, and impactful research. To learn more about our screening process or to discuss potential collaboration, please contact us today.